Literature DB >> 1730550

Corneal autofluorescence: an indicator of diabetic retinopathy.

T R Stolwijk1, J A van Best, J A Oosterhuis, W Swart.   

Abstract

The metabolic disorder in diabetics often results in progressive retinopathy with severe visual impairment. Changes in metabolism can influence corneal autofluorescence. This has led to speculation that diabetic retinopathy might be associated with changes in corneal autofluorescence. Corneal autofluorescence of both eyes was determined by fluorophotometry in 94 insulin-dependent diabetes mellitus patients and in 46 healthy controls to evaluate its correlation with diabetic retinopathy. The modified Airlie House classification was used for grading diabetic retinopathy: (1) no or negligible retinopathy; (2) minimal background retinopathy; (3) background retinopathy; and (4) (pre-) proliferative retinopathy. The corneal autofluorescence values of grade 1 retinopathy patients did not differ significantly from those of the healthy controls (mean +/- standard deviation in ng equivalent fluorescein/ml: 11.6 +/- 3.0 and 11.4 +/- 2.8, respectively; P = 0.8). The means of grade 2, 3, and 4 retinopathy patients (mean +/- standard deviation in ngEq fluorescein/ml: 16.2 +/- 4.4, 16.7 +/- 4.3, 20.9 +/- 5.4, respectively) were significantly higher than the means of grade 1 patients and healthy controls (P less than 0.004). The mean values of patients with grade 4 were significantly higher than those of patients with grades 2 and 3 (P less than 0.01). The sensitivity and specificity of corneal autofluorescence as a screening test for diabetic retinopathy were 80% and 76%, respectively; the positive predictive value for the presence of retinopathy was 90%. The values for screening on (pre-) proliferative diabetic retinopathy were 68%, 72%, and 58%, respectively. These data show corneal autofluorescence to be an adequate indicator of diabetic retinopathy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1730550

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Functional measurements on the enlarged endothelial cells of corneal transplants.

Authors:  W M Bourne
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 2.  Optical quality of the diabetic eye: a review.

Authors:  A M Calvo-Maroto; R J Perez-Cambrodí; C Albarán-Diego; A Pons; A Cerviño
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

3.  Identification of autofluorescent cells in human angioimmunoblastic T-cell lymphoma.

Authors:  Igor Buchwalow; Dmitri Atiakshin; Vera Samoilova; Werner Boecker; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2017-12-02       Impact factor: 4.304

4.  Corneal autofluorescence in choroidal melanoma or in choroidal naevus.

Authors:  R P Müskens; J A Van Best; J C Bleeker; J E Keunen
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

5.  Simultaneous evaluation of tear turnover and corneal epithelial permeability by fluorophotometry in normal subjects and patients with keratoconjunctivitis sicca (KCS).

Authors:  J D Nelson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

6.  Evaluation of antioxidative enzymes levels and lipid peroxidation products levels in diabetic and non diabetic senile cataract patients.

Authors:  Swathy Govindaswamy; Umamahaswara Reddy C; Suhas Prabhakar
Journal:  J Diabetes Metab Disord       Date:  2022-04-01

7.  Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma.

Authors:  C de Jong; T Stolwijk; E Kuppens; R de Keizer; J van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

8.  Topical timolol, corneal epithelial permeability and autofluorescence in glaucoma by fluorophotometry.

Authors:  E Kuppens; T Stolwijk; J van Best; R de Keizer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

9.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.